## **Core Concept**
The core concept being tested here is the serological diagnosis of acute hepatitis B infection. Hepatitis B virus (HBV) infection can be diagnosed and monitored using various serological markers.

## **Why the Correct Answer is Right**
The correct answer, **IgM anti-HBc (Hepatitis B core antibody)**, is a marker of acute hepatitis B infection. During acute HBV infection, the body produces IgM antibodies against the core antigen of the virus (anti-HBc IgM). These antibodies appear early in the course of the disease and persist for about 6 months. The presence of **IgM anti-HBc** is a reliable indicator of acute or recent HBV infection.

## **Why Each Wrong Option is Incorrect**
- **Option A: HBsAg (Hepatitis B surface antigen)**. While HBsAg is a marker for HBV infection, it does not differentiate between acute and chronic infection as it appears in both conditions.
- **Option B: Anti-HBs (Antibody to Hepatitis B surface antigen)**. This indicates immunity to HBV, either through vaccination or past infection, and does not specifically diagnose acute infection.
- **Option D: Anti-HBe (Antibody to Hepatitis B e-antigen)**. This marker indicates a response to the e-antigen of the virus and suggests a transition to a less infectious phase in chronic HBV infection, not acute infection.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **IgM anti-HBc** is the serological marker that signifies acute hepatitis B infection. This is crucial for diagnosing acute HBV infection early, which is vital for initiating appropriate management and preventing further transmission.

## **Correct Answer: C. IgM anti-HBc.**